文献速递免疫规划卫生政策与健康促进

个性化疫苗学:综述

Personalized vaccinology: A review.
PubMed 文献 · Vaccine · 2017-07-31

本文综述疫苗组学、不良反应组学与个性化疫苗学领域,指出当前疫苗学仍多属经验性,从系统生物学层面整合固有、体液和细胞免疫应答的全局分析可推进对疫苗免疫原性、风险与个体化接种的理解。

要点

  • 疫苗学至今多属经验性,疫苗开发与免疫原性多沿用分离-灭活-注射模式。
  • 公共卫生既往采用同病同剂量的群体模式,近年才关注老年人免疫衰老问题。
  • 疫苗组学与不良反应组学可在系统生物学层面整合固有、体液和细胞免疫应答。

核心结论

  • 对疫苗免疫应答如何产生的认识不足是理解老年人与免疫不成熟者疫苗应答差、发现疫苗免疫原性新关联标志物及定向开发新疫苗的关键障碍。
  • 疫苗组学与不良反应组学在系统生物学层面整合固有、体液和细胞免疫应答的全局分析,超越还原论方法,揭示免疫系统与其他生物系统间对下游适应性应答至关重要的新相互作用。
  • 此类方法可实现个性化疫苗学实践,类似于个体化医学在其他健康与医学领域的进展。

研究设计与样本

  • 本文为综述,简要回顾疫苗组学、不良反应组学与个性化疫苗学领域。

主要发现

  • 当前疫苗学领域在许多方面仍属经验性,疫苗开发、免疫原性及效力历史上多由分离-灭活-注射的经验范式驱动。
  • 公共卫生领域既往对疫苗可预防传染病的预防采用同病同剂量的群体模式,且直至近期尚无疫苗专门针对衰老相关的免疫衰老设计。
  • 疫苗组学与不良反应组学提供在系统生物学层面整合固有、体液和细胞免疫应答的全局分析模型,揭示免疫系统与其他生物系统间超越转录水平的新相互作用。
  • 已有研究将系统层面方法用于抗体应答研究(即系统血清学)、通过CyTOF进行高维细胞亚群免疫表型分析及疫苗诱导的代谢变化研究。
  • 上述知识被用于更好地识别谁面临何种感染风险、免疫原性差或严重不良事件的风险水平以及充分保护个体所需的疫苗类型或剂量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

At the current time, the field of vaccinology remains empirical in many respects. Vaccine development, vaccine immunogenicity, and vaccine efficacy have, for the most part, historically been driven by an empiric "isolate-inactivate-inject" paradigm. In turn, a population-level public health paradigm of "the same dose for everyone for every disease" model has been the normative thinking in regard to prevention of vaccine-preventable infectious diseases. In addition, up until recently, no vaccines had been designed specifically to overcome the immunosenescence of aging, consistent with a post-WWII mentality of developing vaccines and vaccine programs for children. It is now recognized that the current lack of knowledge concerning how immune responses to vaccines are generated is a critical barrier to understanding poor vaccine responses in the elderly and in immunoimmaturity, discovery of new correlates of vaccine immunogenicity (vaccine response biomarkers), and a directed approach to new vaccine development. The new fields of vaccinomics and adversomics provide models that permit global profiling of the innate, humoral, and cellular immune responses integrated at a systems biology level. This has advanced the science beyond that of reductionist scientific approaches by revealing novel interactions between and within the immune system and other biological systems (beyond transcriptional level), which are critical to developing "downstream" adaptive humoral and cellular responses to infectious pathogens and vaccines. Others have applied systems level approaches to the study of antibody responses (a.k.a. "systems serology"), [1] high-dimensional cell subset immunophenotyping through CyTOF, [2,3] and vaccine induced metabolic changes [4]. In turn, this knowledge is being utilized to better understand the following: identifying who is at risk for which infections; the level of risk that exists regarding poor immunogenicity and/or serious adverse events; and the type or dose of vaccine needed to fully protect an individual. In toto, such approaches allow for a personalized approach to the practice of vaccinology, analogous to the substantial inroads that individualized medicine is playing in other fields of human health and medicine. Herein we briefly review the field of vaccinomics, adversomics, and personalized vaccinology.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Poland GA, Ovsyannikova IG, Kennedy RB, et al. Personalized vaccinology: A review. Vaccine. 2017. PMID: 28774561. doi:10.1016/j.vaccine.2017.07.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。